Adenovirus News and Research

RSS
Adenoviruses most commonly cause respiratory illness; however, depending on the infecting serotype, they may also cause various other illnesses, such as gastroenteritis, conjunctivitis, cystitis, and rash illness. Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress.
COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

Researchers examine the importance of time after COVID-19 vaccination

Researchers examine the importance of time after COVID-19 vaccination

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern

Could the COVID-19 vaccination rollout protect against future coronavirus outbreaks?

Could the COVID-19 vaccination rollout protect against future coronavirus outbreaks?

Could the intranasal route be an alternate avenue of COVID-19 vaccination?

Could the intranasal route be an alternate avenue of COVID-19 vaccination?

The great promise of antiviral peptides against SARS-CoV-2

The great promise of antiviral peptides against SARS-CoV-2

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

B.1.617.2 variant of SARS-CoV-2 is partially resistant to antibody-mediated neutralization

B.1.617.2 variant of SARS-CoV-2 is partially resistant to antibody-mediated neutralization

Do vaccinations result in anti-SARS-CoV-2 antibodies in human milk?

Do vaccinations result in anti-SARS-CoV-2 antibodies in human milk?

Do mixed COVID-19 vaccines provide immunity?

Do mixed COVID-19 vaccines provide immunity?

SARS-CoV-2 vaccines from Pfizer-BioNTech and AstraZeneca reduce mortality among the elderly

SARS-CoV-2 vaccines from Pfizer-BioNTech and AstraZeneca reduce mortality among the elderly

Spike antibodies after vaccination with Pfizer and Oxford vaccines

Spike antibodies after vaccination with Pfizer and Oxford vaccines

Sequentia collaborated with Nextbiomics to obtain a novel immunization model against COVID-19

Sequentia collaborated with Nextbiomics to obtain a novel immunization model against COVID-19

Presence of Anti-SARS-CoV-2 antibodies after 13 months of infection

Presence of Anti-SARS-CoV-2 antibodies after 13 months of infection

Antibody response following SARS-CoV-2 mRNA vaccine is greater than natural infection

Antibody response following SARS-CoV-2 mRNA vaccine is greater than natural infection

New technology tricks tumors to eliminate itself through the production of anti-cancer agents

New technology tricks tumors to eliminate itself through the production of anti-cancer agents

Single dose of Oxford-AstraZeneca vaccine protective in previously infected recipients, suggests study

Single dose of Oxford-AstraZeneca vaccine protective in previously infected recipients, suggests study

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

This small Canadian drugmaker wants to make J&J vaccines for poor nations. It needs more than a patent waiver.

This small Canadian drugmaker wants to make J&J vaccines for poor nations. It needs more than a patent waiver.